Has anyone made an appointment for the HPV nine-valent vaccine on Rainbow Parenting in Ali Health?

At present, it is generally difficult to make an appointment.

The nine-valent HPV vaccine is used to prevent cervical cancer caused by human papillomavirus (HPV) infection and can prevent more than 90% of cervical cancer. The vaccine was approved for marketing in the United States in 2014.

On April 28, 2018, the State Food and Drug Administration conditionally approved the nine-valent HPV vaccine for the prevention of cervical cancer to be launched in China. Vaccination is primary prevention, and screening is secondary prevention. Both are equally important. Therefore, cervical cancer screening measures should not be relaxed due to vaccination.

The nine-valent HPV vaccine has good immunogenicity. After completing the three-dose vaccination process, the seroconversion rate of relevant types of serum antibodies can reach almost 100%. One month after completing the vaccination program, the peak geometric mean antibody titer can reach 100 times the antibody level after natural infection. In the next 2 months, the value drops to 10 times and remains at a plateau.

The antibody level of the vaccine can be maintained for at least 4 years. In clinical trials of the efficacy of the nine-valent HPV vaccine, the primary endpoints were persistent infection with relevant HPV types, genital warts associated with relevant HPV types, cervical intraepithelial neoplasia (CIN), and external genital or vaginal intraepithelial neoplasia. Neoplasia (VIN or VaIN).

Reference for the above content: Baidu Encyclopedia-9-valent vaccine